Searching the RRID Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Preparing word cloud

×

Suggested Search Criteria

Enter extra filters to help narrow your search

Search

Type in a keyword to search

Filter by records added date
See new records

Options


Current Facets and Filters

  • Mentions:yes (facet)

Facets


Recent searches

Snippet view Table view
Click the to add this resource to an Authentication Report or Collection

10,882 Results - per page

Show More Columns | Download Top 1000 Results

Name Proper Citation Organism Disease Comments Defining Citation Category Sex Synonyms Vendor Catalog Number Cross References Hierarchy Originate from Same Individual ID Record Last Update Mentions Count
HEK293-H
 
Resource Report
Resource Website
1+ mentions
RRID:CVCL_6643 Homo sapiens (Human) Group: Serum/protein free medium cell line. Transformed cell line Female HEK-293-H, HEK 293-H, HEK-293H, HEK 293H, HEK293H, 293-H, 293 H, 293H BTO:BTO_0003033,
EFO:EFO_0001183,
Lonza:1420,
TOKU-E:3991,
Wikidata:Q54882458
cvcl_0045 CVCL_6643 2026-09-05 11:02:39 7
HEK293T(DMT1)
 
Resource Report
Resource Website
10+ mentions
RRID:CVCL_HA71 Homo sapiens (Human) Characteristics: Useful to screen for potential iron transport inhibitors (Kerafast=EF4002). PMID:16984886 Transformed cell line Female DMT1 Expressing HEK293T Cell Line ABM:T6000,
Kerafast:EF4002,
Wikidata:Q54882492
cvcl_0063 CVCL_HA71 2026-09-05 11:02:40 17
HEKR1
 
Resource Report
Resource Website
1+ mentions
RRID:CVCL_HB83 Homo sapiens (Human) Transformed cell line Female Kerafast:EUR031,
Wikidata:Q54882495
cvcl_0045 CVCL_HB83 2026-09-05 11:02:40 2
HEK293S
 
Resource Report
Resource Website
100+ mentions
RRID:CVCL_A784 Homo sapiens (Human) Characteristics: Adapted to growth in suspension. PMID:8876162
PMID:10736692
PMID:25182477
Transformed cell line Female HEK-293S, HEK 293S, 293S BTO:BTO_0006453,
EFO:EFO_0022515,
BioSamples:SAMEA2168959,
CancerTools:154155,
Wikidata:Q54882484
cvcl_0045 CVCL_A784 2026-09-05 11:02:39 419
HEL 299
 
Resource Report
Resource Website
1+ mentions
AddexBio Cat# T0016051/5020, RRID:CVCL_2480 Homo sapiens (Human) Population: African American. PMID:375235
PMID:6254071
PMID:6988327
PMID:7065527
Finite cell line Male HEL-299, Hel-299, Hel 299, HEL299 AddexBio T0016051/5020 CLO:CLO_0003681,
CLDB:cl1586,
CLDB:cl1587,
CLDB:cl1589,
CLDB:cl1590,
AddexBio:T0016051/5020,
ATCC:CCL-137,
BCRC:60117,
BioSample:SAMN03471455,
CCRID:5301HUM-KCB15024YJ,
ChEMBL-Cells:CHEMBL3308663,
ChEMBL-Targets:CHEMBL614819,
CLS:300193,
ECACC:87042207,
IPD-IMGT/HLA:10725,
IZSLER:BS CL 49,
KCB:KCB 2015024YJ,
KCLB:10137,
PubChem_Cell_line:CVCL_2480,
Wikidata:Q54882503
CVCL_2480 2026-09-05 11:02:40 7
HEL 299
 
Resource Report
Resource Website
1+ mentions
IZSLER Cat# BS CL 49, RRID:CVCL_2480 Homo sapiens (Human) Population: African American. PMID:375235
PMID:6254071
PMID:6988327
PMID:7065527
Finite cell line Male HEL-299, Hel-299, Hel 299, HEL299 IZSLER BS CL 49 CLO:CLO_0003681,
CLDB:cl1586,
CLDB:cl1587,
CLDB:cl1589,
CLDB:cl1590,
AddexBio:T0016051/5020,
ATCC:CCL-137,
BCRC:60117,
BioSample:SAMN03471455,
CCRID:5301HUM-KCB15024YJ,
ChEMBL-Cells:CHEMBL3308663,
ChEMBL-Targets:CHEMBL614819,
CLS:300193,
ECACC:87042207,
IPD-IMGT/HLA:10725,
IZSLER:BS CL 49,
KCB:KCB 2015024YJ,
KCLB:10137,
PubChem_Cell_line:CVCL_2480,
Wikidata:Q54882503
CVCL_2480 2026-09-05 11:02:40 7
HEL
 
Resource Report
Resource Website
10+ mentions
RRID:CVCL_0001 Homo sapiens (Human) Erythroleukemia Donor information: Originally the patient was suffering from Hodgkin lymphoma., Population: Caucasian., Part of: LL-100 blood cancer cell line panel., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). PMID:2985879
PMID:3159941
PMID:3874327
PMID:6177045
PMID:7538619
PMID:8558913
PMID:9290701
PMID:9510473
PMID:9738977
PMID:10739008
PMID:11021758
PMID:11226526
PMID:14504097
PMID:16408098
PMID:16957166
PMID:20164919
PMID:22460905
PMID:23955599
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27277069
PMID:27397505
PMID:29533902
PMID:30285677
PMID:30629668
PMID:30894373
PMID:31068700
PMID:31160637
PMID:31978347
PMID:35839778
PMID:36982453
Cancer cell line Male Hel, GM06141, GM06141B, Human ErythroLeukemia BTO:BTO_0000565,
CLO:CLO_0003679,
CLO:CLO_0023565,
EFO:EFO_0006579,
MCCL:MCC:0000187,
CLDB:cl0,
CLDB:cl1585,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ArrayExpress:E-MTAB-7721,
ArrayExpress:E-MTAB-7722,
BioGRID_ORCS_Cell_line:210,
BioSample:SAMN03471056,
BioSample:SAMN03472269,
BioSample:SAMN10987697,
cancercelllines:CVCL_0001,
CCRID:3101HUMTCHu71,
CCRID:4201HUM-CCTCC00071,
CCTCC:GDC0071,
Cell_Model_Passport:SIDM00594,
ChEMBL-Cells:CHEMBL3308090,
ChEMBL-Targets:CHEMBL613888,
CLS:305022,
Coriell:GM06141,
Cosmic:787432,
Cosmic:798663,
Cosmic:850392,
Cosmic:907053,
Cosmic:919128,
Cosmic:924040,
Cosmic:947363,
Cosmic:975251,
Cosmic:976722,
Cosmic:994176,
Cosmic:996314,
Cosmic:1012051,
Cosmic:1013868,
Cosmic:1037665,
Cosmic:1070698,
Cosmic:1078733,
Cosmic:1122162,
Cosmic:1127268,
Cosmic:1139508,
Cosmic:1139638,
Cosmic:1140092,
Cosmic:1151879,
Cosmic:1168467,
Cosmic:1170892,
Cosmic:1171333,
Cosmic:1176583,
Cosmic:1191710,
Cosmic:1192825,
Cosmic:1601067,
Cosmic:1604866,
Cosmic:1633512,
Cosmic:1943609,
Cosmic:2089667,
Cosmic:2131538,
Cosmic:2306207,
Cosmic:2649243,
Cosmic-CLP:907053,
DepMap:ACH-000004,
DSMZ:ACC-11,
DSMZCellDive:ACC-11,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:EGAS00001002554,
GDSC:907053,
GEO:GSM482506,
GEO:GSM743410,
GEO:GSM887077,
GEO:GSM888147,
GEO:GSM1028243,
GEO:GSM1446763,
GEO:GSM1669874,
GEO:GSM7701373,
GEO:GSM7701374,
IARC_TP53:21368,
JCRB:JCRB0062,
KCB:KCB 200808YJ,
LiGeA:CCLE_453,
LINCS_LDP:LCL-1053,
PharmacoDB:HEL_534_2019,
PRIDE:PXD030304,
Progenetix:CVCL_0001,
PubChem_Cell_line:CVCL_0001,
Ubigene:YC-C090,
Wikidata:Q54882501
CVCL_0001 2026-09-05 11:02:40 25
HEL 299
 
Resource Report
Resource Website
1+ mentions
KCB Cat# KCB 2015024YJ, RRID:CVCL_2480 Homo sapiens (Human) Population: African American. PMID:375235
PMID:6254071
PMID:6988327
PMID:7065527
Finite cell line Male HEL-299, Hel-299, Hel 299, HEL299 KCB KCB 2015024YJ CLO:CLO_0003681,
CLDB:cl1586,
CLDB:cl1587,
CLDB:cl1589,
CLDB:cl1590,
AddexBio:T0016051/5020,
ATCC:CCL-137,
BCRC:60117,
BioSample:SAMN03471455,
CCRID:5301HUM-KCB15024YJ,
ChEMBL-Cells:CHEMBL3308663,
ChEMBL-Targets:CHEMBL614819,
CLS:300193,
ECACC:87042207,
IPD-IMGT/HLA:10725,
IZSLER:BS CL 49,
KCB:KCB 2015024YJ,
KCLB:10137,
PubChem_Cell_line:CVCL_2480,
Wikidata:Q54882503
CVCL_2480 2026-09-05 11:02:40 7
HEL 299
 
Resource Report
Resource Website
1+ mentions
BCRC Cat# 60117, RRID:CVCL_2480 Homo sapiens (Human) Population: African American. PMID:375235
PMID:6254071
PMID:6988327
PMID:7065527
Finite cell line Male HEL-299, Hel-299, Hel 299, HEL299 BCRC 60117 CLO:CLO_0003681,
CLDB:cl1586,
CLDB:cl1587,
CLDB:cl1589,
CLDB:cl1590,
AddexBio:T0016051/5020,
ATCC:CCL-137,
BCRC:60117,
BioSample:SAMN03471455,
CCRID:5301HUM-KCB15024YJ,
ChEMBL-Cells:CHEMBL3308663,
ChEMBL-Targets:CHEMBL614819,
CLS:300193,
ECACC:87042207,
IPD-IMGT/HLA:10725,
IZSLER:BS CL 49,
KCB:KCB 2015024YJ,
KCLB:10137,
PubChem_Cell_line:CVCL_2480,
Wikidata:Q54882503
CVCL_2480 2026-09-05 11:02:40 7
HEK293A/GFP-LC3
 
Resource Report
Resource Website
1+ mentions
RRID:CVCL_W347 Homo sapiens (Human) PMID:16420522 Transformed cell line Female HEK293A GFP-LC3, HEK293A GFP LC3, HEK293/GFP-LC3, EK293A EGFP-LC3, 293/GFP-LC3 CancerTools:151480,
ECACC:14050801,
Wikidata:Q54882480,
Ximbio:151480
cvcl_6910 CVCL_W347 2026-09-05 11:02:39 2
HEK293T/17
 
Resource Report
Resource Website
1000+ mentions
RRID:CVCL_1926 Homo sapiens (Human) Group: Patented cell line. PMID:7690960 Transformed cell line Female HEK-293T/17, HEK 293T/17, 293T/17 BTO:BTO_0006328,
CLO:CLO_0001235,
ATCC:CRL-11268,
BioSample:SAMN03471332,
CCRID:1101HUM-PUMC000212,
CCRID:3101HUMGNHu44,
CLS:305117,
TOKU-E:245,
Wikidata:Q28178058
cvcl_0063 CVCL_1926 2026-09-05 11:02:40 1703
HEL 299
 
Resource Report
Resource Website
1+ mentions
ECACC Cat# 87042207, RRID:CVCL_2480 Homo sapiens (Human) Population: African American. PMID:375235
PMID:6254071
PMID:6988327
PMID:7065527
Finite cell line Male HEL-299, Hel-299, Hel 299, HEL299 ECACC 87042207 CLO:CLO_0003681,
CLDB:cl1586,
CLDB:cl1587,
CLDB:cl1589,
CLDB:cl1590,
AddexBio:T0016051/5020,
ATCC:CCL-137,
BCRC:60117,
BioSample:SAMN03471455,
CCRID:5301HUM-KCB15024YJ,
ChEMBL-Cells:CHEMBL3308663,
ChEMBL-Targets:CHEMBL614819,
CLS:300193,
ECACC:87042207,
IPD-IMGT/HLA:10725,
IZSLER:BS CL 49,
KCB:KCB 2015024YJ,
KCLB:10137,
PubChem_Cell_line:CVCL_2480,
Wikidata:Q54882503
CVCL_2480 2026-09-05 11:02:40 7
HEKR3
 
Resource Report
Resource Website
1+ mentions
RRID:CVCL_HB87 Homo sapiens (Human) Transformed cell line Female Kerafast:EUR033,
Wikidata:Q54882499
cvcl_0045 CVCL_HB87 2026-09-05 11:02:40 1
HEL 92.1.7
 
Resource Report
Resource Website
10+ mentions
RRID:CVCL_2481 Homo sapiens (Human) Erythroleukemia Donor information: Originally the patient was suffering from Hodgkin lymphoma., Population: Caucasian., Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981)., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). PMID:20215515
PMID:22460905
PMID:30285677
PMID:30894373
PMID:31068700
PMID:31978347
Cancer cell line Male HEL92.1.7, HEL-92.1.7, HEL-92-1-7, HEL-92_1_7, HEL-92, HEL9217 BTO:BTO_0003320,
CLO:CLO_0003682,
CLO:CLO_0003683,
EFO:EFO_0002193,
CLDB:cl5067,
CLDB:cl7132,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-2770,
ATCC:TIB-180,
BCRC:60370,
BCRJ:0308,
BioSample:SAMN10987842,
cancercelllines:CVCL_2481,
Cell_Model_Passport:SIDM00593,
ChEMBL-Cells:CHEMBL4295457,
ChEMBL-Targets:CHEMBL4296425,
CLS:300462,
Cosmic:683543,
Cosmic:976723,
DepMap:ACH-000005,
ECACC:92111706,
GEO:GSM887076,
GEO:GSM888146,
GEO:GSM1374526,
GEO:GSM1374527,
IARC_TP53:21369,
ICLC:HTL03002,
IGRhCellID:HEL9217,
LiGeA:CCLE_672,
LINCS_LDP:LCL-1076,
Lonza:1042,
PharmacoDB:HEL92_1_7_535_2019,
Progenetix:CVCL_2481,
PubChem_Cell_line:CVCL_2481,
Wikidata:Q54882504
cvcl_0001 CVCL_2481 2026-09-05 11:02:40 32
HeLa FUS KO
 
Resource Report
Resource Website
1+ mentions
RRID:CVCL_A8VH Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Population: African American. PMID:37384305 Cancer cell line Female Wikidata:Q108820451 cvcl_0030 CVCL_A8VH 2026-09-05 11:02:42 1
HeLa Kyoto EGFP-EB3
 
Resource Report
Resource Website
1+ mentions
RRID:CVCL_1D61 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Population: African American. Cancer cell line Female HeLa Kyoto EB3 EGFP, HeLa Kyoto EB3-EGFP CLS:300668,
Wikidata:Q54882542
cvcl_1922 CVCL_1D61 2026-09-05 11:02:42 1
HeLa
 
Resource Report
Resource Website
10000+ mentions
Discontinued
TKG Cat# TKG 0331, RRID:CVCL_0030 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut). PMID:77569
PMID:1246620
PMID:1522048
PMID:2983228
PMID:2990217
PMID:3028716
PMID:3180844
PMID:3371749
PMID:3518877
PMID:4942173
PMID:5668122
PMID:6256643
PMID:6358339
PMID:6401685
PMID:6825208
PMID:6935474
PMID:8380785
PMID:9892199
PMID:10423141
PMID:11416159
PMID:11668190
PMID:12001993
PMID:12661003
PMID:12793746
PMID:13052828
PMID:13207312
PMID:13261081
PMID:14031339
PMID:14185313
PMID:15302935
PMID:15531914
PMID:15901131
PMID:16589695
PMID:16957166
PMID:17311676
PMID:19450234
PMID:19722756
PMID:19941903
PMID:21269460
PMID:21937730
PMID:22068331
PMID:22278370
PMID:22412903
PMID:23205564
PMID:23336012
PMID:23925224
PMID:23925245
PMID:24134916
PMID:24618588
PMID:24696503
PMID:24908793
PMID:25485619
PMID:25807930
PMID:25877200
PMID:25894527
PMID:25960936
PMID:26554430
PMID:26589293
PMID:27397505
PMID:28078501
PMID:28196595
PMID:28261610
PMID:28601559
PMID:29156801
PMID:30175587
PMID:30778230
PMID:30787054
PMID:30894373
PMID:31068700
PMID:31433507
PMID:31790455
PMID:33389257
PMID:35198691
PMID:35839778
PMID:37543987
Cancer cell line Female HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri TKG TKG 0331 BTO:BTO_0000567,
CLO:CLO_0003684,
CLO:CLO_0050910,
EFO:EFO_0001185,
MCCL:MCC:0000219,
CLDB:cl1594,
CLDB:cl1595,
CLDB:cl1596,
CLDB:cl1597,
CLDB:cl1599,
CLDB:cl1600,
CLDB:cl1601,
CLDB:cl1603,
Abcam:ab255448,
Abcam:ab255928,
Abcam:ab260075,
Abcam:ab271142,
Abcam:ab275466,
AddexBio:C0008001/44,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
ATCC:CCL-2,
ATCC:CRL-7923,
ATCC:CRM-CCL-2,
BCRC:60005,
BCRJ:0100,
BEI_Resources:ARP-153,
BioGRID_ORCS_Cell_line:95,
BioSample:SAMN03471148,
BioSample:SAMN03472333,
BioSample:SAMN10989629,
cancercelllines:CVCL_0030,
CCLV:CCLV-RIE 0082,
CCRID:1101HUM-PUMC000011,
CCRID:1101HUM-PUMC000332,
CCRID:1102HUM-NIFDC00057,
CCRID:3101HUMSCSP504,
CCRID:3101HUMTCHu187,
CCRID:4201HUM-CCTCC00009,
CCRID:5301HUM-KCB90024YJ,
CCTCC:GDC0009,
Cell_Model_Passport:SIDM00846,
ChEMBL-Cells:CHEMBL3308376,
ChEMBL-Targets:CHEMBL399,
CLS:300194,
Cosmic:760219,
Cosmic:760490,
Cosmic:801357,
Cosmic:809231,
Cosmic:877477,
Cosmic:911999,
Cosmic:925354,
Cosmic:928907,
Cosmic:944113,
Cosmic:1019309,
Cosmic:1057766,
Cosmic:1071911,
Cosmic:1131525,
Cosmic:1193029,
Cosmic:1201779,
Cosmic:1324208,
Cosmic:1336880,
Cosmic:1571796,
Cosmic:2301539,
Cosmic:2660190,
Cosmic:2750874,
Cosmic:2791019,
Cosmic:2816214,
Cosmic-CLP:1298134,
dbGAP:phs000640.v4.p1,
DepMap:ACH-001086,
DSMZ:ACC-57,
DSMZCellDive:ACC-57,
ECACC:93021013,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:phs000640,
FCS-free:44-2-47-1-8-9,
GDSC:1298134,
GEO:GSM113863,
GEO:GSM226739,
GEO:GSM226875,
GEO:GSM253298,
GEO:GSM436128,
GEO:GSM436129,
GEO:GSM501788,
GEO:GSM722574,
GEO:GSM722575,
GEO:GSM723055,
GEO:GSM723056,
GEO:GSM1088663,
GEO:GSM1088664,
GEO:GSM1088665,
GEO:GSM1088666,
GEO:GSM1374528,
GEO:GSM1669875,
GEO:GSM1881473,
GEO:GSM1881474,
GEO:GSM1881475,
GEO:GSM7701367,
GEO:GSM7701368,
Hysigen:TCH-C193,
ICLC:HTL95023,
IGRhCellID:HeLA,
IZSLER:BS TCL 20,
JCRB:JCRB9004,
KCB:KCB 86019YJ,
KCB:KCB 90024YJ,
KCLB:10002,
LINCS_HMS:50061,
LINCS_LDP:LCL-1512,
Lonza:51,
MeSH:D006367,
NCBI_Iran:C115,
PharmacoDB:HeLa_536_2019,
PRIDE:PRD000007,
PRIDE:PRD000032,
PRIDE:PRD000123,
PRIDE:PRD000124,
PRIDE:PRD000345,
PRIDE:PRD000376,
PRIDE:PRD000525,
PRIDE:PRD000526,
PRIDE:PRD000527,
PRIDE:PXD000013,
PRIDE:PXD000243,
PRIDE:PXD000252,
PRIDE:PXD000279,
PRIDE:PXD000396,
PRIDE:PXD000474,
PRIDE:PXD000589,
PRIDE:PXD000661,
PRIDE:PXD000680,
PRIDE:PXD000759,
PRIDE:PXD000883,
PRIDE:PXD000895,
PRIDE:PXD000900,
PRIDE:PXD000953,
PRIDE:PXD000954,
PRIDE:PXD000999,
PRIDE:PXD001047,
PRIDE:PXD001118,
PRIDE:PXD001154,
PRIDE:PXD001175,
PRIDE:PXD001249,
PRIDE:PXD001258,
PRIDE:PXD001259,
PRIDE:PXD001278,
PRIDE:PXD001305,
PRIDE:PXD001374,
PRIDE:PXD001381,
PRIDE:PXD001396,
PRIDE:PXD001441,
PRIDE:PXD001541,
PRIDE:PXD001548,
PRIDE:PXD001574,
PRIDE:PXD001660,
PRIDE:PXD001781,
PRIDE:PXD001798,
PRIDE:PXD001805,
PRIDE:PXD001806,
PRIDE:PXD001810,
PRIDE:PXD001863,
PRIDE:PXD001907,
PRIDE:PXD002001,
PRIDE:PXD002039,
PRIDE:PXD002066,
PRIDE:PXD002252,
PRIDE:PXD002277,
PRIDE:PXD002378,
PRIDE:PXD002383,
PRIDE:PXD002395,
PRIDE:PXD002572,
PRIDE:PXD002591,
PRIDE:PXD002704,
PRIDE:PXD002844,
PRIDE:PXD002880,
PRIDE:PXD003186,
PRIDE:PXD003209,
PRIDE:PXD003258,
PRIDE:PXD003370,
PRIDE:PXD003503,
PRIDE:PXD003530,
PRIDE:PXD003560,
PRIDE:PXD003792,
PRIDE:PXD003813,
PRIDE:PXD003909,
PRIDE:PXD003913,
PRIDE:PXD003917,
PRIDE:PXD003924,
PRIDE:PXD004182,
PRIDE:PXD004271,
PRIDE:PXD004273,
PRIDE:PXD004452,
PRIDE:PXD004613,
PRIDE:PXD004736,
PRIDE:PXD004900,
PRIDE:PXD004914,
PRIDE:PXD004933,
PRIDE:PXD004934,
PRIDE:PXD004940,
PRIDE:PXD004995,
PRIDE:PXD005018,
PRIDE:PXD005107,
PRIDE:PXD005181,
PRIDE:PXD005346,
PRIDE:PXD005349,
PRIDE:PXD005366,
PRIDE:PXD005466,
PRIDE:PXD005509,
PRIDE:PXD005572,
PRIDE:PXD005712,
PRIDE:PXD005955,
PRIDE:PXD006112,
PRIDE:PXD006293,
PRIDE:PXD012045,
PRIDE:PXD012188,
PRIDE:PXD013064,
PRIDE:PXD023271,
PRIDE:PXD023835,
PRIDE:PXD027504,
PRIDE:PXD029773,
PRIDE:PXD030304,
Progenetix:CVCL_0030,
PubChem_Cell_line:CVCL_0030,
RCB:RCB0007,
RCB:RCB3680,
SKY/M-FISH/CGH:5351,
TKG:TKG 0331,
TOKU-E:1434,
Ubigene:YC-A012,
Wikidata:Q847482
CVCL_0030 2026-09-05 11:02:41 39236
HeLa
 
Resource Report
Resource Website
10000+ mentions
Discontinued
ATCC Cat# CCL-2, RRID:CVCL_0030 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut). PMID:77569
PMID:1246620
PMID:1522048
PMID:2983228
PMID:2990217
PMID:3028716
PMID:3180844
PMID:3371749
PMID:3518877
PMID:4942173
PMID:5668122
PMID:6256643
PMID:6358339
PMID:6401685
PMID:6825208
PMID:6935474
PMID:8380785
PMID:9892199
PMID:10423141
PMID:11416159
PMID:11668190
PMID:12001993
PMID:12661003
PMID:12793746
PMID:13052828
PMID:13207312
PMID:13261081
PMID:14031339
PMID:14185313
PMID:15302935
PMID:15531914
PMID:15901131
PMID:16589695
PMID:16957166
PMID:17311676
PMID:19450234
PMID:19722756
PMID:19941903
PMID:21269460
PMID:21937730
PMID:22068331
PMID:22278370
PMID:22412903
PMID:23205564
PMID:23336012
PMID:23925224
PMID:23925245
PMID:24134916
PMID:24618588
PMID:24696503
PMID:24908793
PMID:25485619
PMID:25807930
PMID:25877200
PMID:25894527
PMID:25960936
PMID:26554430
PMID:26589293
PMID:27397505
PMID:28078501
PMID:28196595
PMID:28261610
PMID:28601559
PMID:29156801
PMID:30175587
PMID:30778230
PMID:30787054
PMID:30894373
PMID:31068700
PMID:31433507
PMID:31790455
PMID:33389257
PMID:35198691
PMID:35839778
PMID:37543987
Cancer cell line Female HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri ATCC CCL-2 BTO:BTO_0000567,
CLO:CLO_0003684,
CLO:CLO_0050910,
EFO:EFO_0001185,
MCCL:MCC:0000219,
CLDB:cl1594,
CLDB:cl1595,
CLDB:cl1596,
CLDB:cl1597,
CLDB:cl1599,
CLDB:cl1600,
CLDB:cl1601,
CLDB:cl1603,
Abcam:ab255448,
Abcam:ab255928,
Abcam:ab260075,
Abcam:ab271142,
Abcam:ab275466,
AddexBio:C0008001/44,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
ATCC:CCL-2,
ATCC:CRL-7923,
ATCC:CRM-CCL-2,
BCRC:60005,
BCRJ:0100,
BEI_Resources:ARP-153,
BioGRID_ORCS_Cell_line:95,
BioSample:SAMN03471148,
BioSample:SAMN03472333,
BioSample:SAMN10989629,
cancercelllines:CVCL_0030,
CCLV:CCLV-RIE 0082,
CCRID:1101HUM-PUMC000011,
CCRID:1101HUM-PUMC000332,
CCRID:1102HUM-NIFDC00057,
CCRID:3101HUMSCSP504,
CCRID:3101HUMTCHu187,
CCRID:4201HUM-CCTCC00009,
CCRID:5301HUM-KCB90024YJ,
CCTCC:GDC0009,
Cell_Model_Passport:SIDM00846,
ChEMBL-Cells:CHEMBL3308376,
ChEMBL-Targets:CHEMBL399,
CLS:300194,
Cosmic:760219,
Cosmic:760490,
Cosmic:801357,
Cosmic:809231,
Cosmic:877477,
Cosmic:911999,
Cosmic:925354,
Cosmic:928907,
Cosmic:944113,
Cosmic:1019309,
Cosmic:1057766,
Cosmic:1071911,
Cosmic:1131525,
Cosmic:1193029,
Cosmic:1201779,
Cosmic:1324208,
Cosmic:1336880,
Cosmic:1571796,
Cosmic:2301539,
Cosmic:2660190,
Cosmic:2750874,
Cosmic:2791019,
Cosmic:2816214,
Cosmic-CLP:1298134,
dbGAP:phs000640.v4.p1,
DepMap:ACH-001086,
DSMZ:ACC-57,
DSMZCellDive:ACC-57,
ECACC:93021013,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:phs000640,
FCS-free:44-2-47-1-8-9,
GDSC:1298134,
GEO:GSM113863,
GEO:GSM226739,
GEO:GSM226875,
GEO:GSM253298,
GEO:GSM436128,
GEO:GSM436129,
GEO:GSM501788,
GEO:GSM722574,
GEO:GSM722575,
GEO:GSM723055,
GEO:GSM723056,
GEO:GSM1088663,
GEO:GSM1088664,
GEO:GSM1088665,
GEO:GSM1088666,
GEO:GSM1374528,
GEO:GSM1669875,
GEO:GSM1881473,
GEO:GSM1881474,
GEO:GSM1881475,
GEO:GSM7701367,
GEO:GSM7701368,
Hysigen:TCH-C193,
ICLC:HTL95023,
IGRhCellID:HeLA,
IZSLER:BS TCL 20,
JCRB:JCRB9004,
KCB:KCB 86019YJ,
KCB:KCB 90024YJ,
KCLB:10002,
LINCS_HMS:50061,
LINCS_LDP:LCL-1512,
Lonza:51,
MeSH:D006367,
NCBI_Iran:C115,
PharmacoDB:HeLa_536_2019,
PRIDE:PRD000007,
PRIDE:PRD000032,
PRIDE:PRD000123,
PRIDE:PRD000124,
PRIDE:PRD000345,
PRIDE:PRD000376,
PRIDE:PRD000525,
PRIDE:PRD000526,
PRIDE:PRD000527,
PRIDE:PXD000013,
PRIDE:PXD000243,
PRIDE:PXD000252,
PRIDE:PXD000279,
PRIDE:PXD000396,
PRIDE:PXD000474,
PRIDE:PXD000589,
PRIDE:PXD000661,
PRIDE:PXD000680,
PRIDE:PXD000759,
PRIDE:PXD000883,
PRIDE:PXD000895,
PRIDE:PXD000900,
PRIDE:PXD000953,
PRIDE:PXD000954,
PRIDE:PXD000999,
PRIDE:PXD001047,
PRIDE:PXD001118,
PRIDE:PXD001154,
PRIDE:PXD001175,
PRIDE:PXD001249,
PRIDE:PXD001258,
PRIDE:PXD001259,
PRIDE:PXD001278,
PRIDE:PXD001305,
PRIDE:PXD001374,
PRIDE:PXD001381,
PRIDE:PXD001396,
PRIDE:PXD001441,
PRIDE:PXD001541,
PRIDE:PXD001548,
PRIDE:PXD001574,
PRIDE:PXD001660,
PRIDE:PXD001781,
PRIDE:PXD001798,
PRIDE:PXD001805,
PRIDE:PXD001806,
PRIDE:PXD001810,
PRIDE:PXD001863,
PRIDE:PXD001907,
PRIDE:PXD002001,
PRIDE:PXD002039,
PRIDE:PXD002066,
PRIDE:PXD002252,
PRIDE:PXD002277,
PRIDE:PXD002378,
PRIDE:PXD002383,
PRIDE:PXD002395,
PRIDE:PXD002572,
PRIDE:PXD002591,
PRIDE:PXD002704,
PRIDE:PXD002844,
PRIDE:PXD002880,
PRIDE:PXD003186,
PRIDE:PXD003209,
PRIDE:PXD003258,
PRIDE:PXD003370,
PRIDE:PXD003503,
PRIDE:PXD003530,
PRIDE:PXD003560,
PRIDE:PXD003792,
PRIDE:PXD003813,
PRIDE:PXD003909,
PRIDE:PXD003913,
PRIDE:PXD003917,
PRIDE:PXD003924,
PRIDE:PXD004182,
PRIDE:PXD004271,
PRIDE:PXD004273,
PRIDE:PXD004452,
PRIDE:PXD004613,
PRIDE:PXD004736,
PRIDE:PXD004900,
PRIDE:PXD004914,
PRIDE:PXD004933,
PRIDE:PXD004934,
PRIDE:PXD004940,
PRIDE:PXD004995,
PRIDE:PXD005018,
PRIDE:PXD005107,
PRIDE:PXD005181,
PRIDE:PXD005346,
PRIDE:PXD005349,
PRIDE:PXD005366,
PRIDE:PXD005466,
PRIDE:PXD005509,
PRIDE:PXD005572,
PRIDE:PXD005712,
PRIDE:PXD005955,
PRIDE:PXD006112,
PRIDE:PXD006293,
PRIDE:PXD012045,
PRIDE:PXD012188,
PRIDE:PXD013064,
PRIDE:PXD023271,
PRIDE:PXD023835,
PRIDE:PXD027504,
PRIDE:PXD029773,
PRIDE:PXD030304,
Progenetix:CVCL_0030,
PubChem_Cell_line:CVCL_0030,
RCB:RCB0007,
RCB:RCB3680,
SKY/M-FISH/CGH:5351,
TKG:TKG 0331,
TOKU-E:1434,
Ubigene:YC-A012,
Wikidata:Q847482
CVCL_0030 2026-09-05 11:02:41 39236
HeLa 229
 
Resource Report
Resource Website
100+ mentions
KCLB Cat# 10002.1, RRID:CVCL_1276 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Population: African American. PMID:1522048
PMID:2754009
PMID:14185313
Cancer cell line Female HeLa-229, HeLa229 KCLB 10002.1 BTO:BTO_0005030,
CLO:CLO_0003685,
CLO:CLO_0003698,
CLDB:cl1604,
CLDB:cl1605,
CLDB:cl1606,
ATCC:CCL-2.1,
BCRC:60290,
CCRID:1101HUM-PUMC000181,
CCRID:3101HUMTCHu20,
CCRID:4201HUM-CCTCC00335,
CCTCC:GDC0335,
ChEMBL-Cells:CHEMBL4483175,
ChEMBL-Targets:CHEMBL4483246,
CLS:305056,
ECACC:86090201,
IZSLER:BS TCL 21,
JCRB:JCRB9086,
KCLB:10002.1,
PubChem_Cell_line:CVCL_1276,
Wikidata:Q54882513
cvcl_0030 CVCL_1276 2026-09-05 11:02:41 321
HeLa DH
 
Resource Report
Resource Website
1+ mentions
ECACC Cat# 96112022, RRID:CVCL_2483 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Population: African American. Cancer cell line Female ECACC 96112022 CLO:CLO_0003690,
ECACC:96112022,
Wikidata:Q54882526
cvcl_0030 CVCL_2483 2026-09-05 11:02:42 5

Can't find your Cell Line?

We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. If you want to find a specific cell line, it's easier to enter an RRID or add the vendor information to search. You can refine the search results using Facets on the left side of the search results page. If you are on the table view, you can also search in a specific column by clicking the column title and enter the keywords.

If you still could not find your cell line in the search results, please help us by registering it into the system — it's easy. Register it with the Cellosaurus. An RRID will be generated in 1-2 business days.

Can't find the RRID you're searching for? X
X
  1. RRID Portal Resources

    Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.

  2. Navigation

    You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.

  3. Logging in and Registering

    If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.

  4. Searching

    Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:

    1. Use quotes around phrases you want to match exactly
    2. You can manually AND and OR terms to change how we search between words
    3. You can add "-" to terms to make sure no results return with that term in them (ex. Cerebellum -CA1)
    4. You can add "+" to terms to require they be in the data
    5. Using autocomplete specifies which branch of our semantics you with to search and can help refine your search
  5. Collections

    If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.

  6. Facets

    Here are the facets that you can filter the data by.

  7. Further Questions

    If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.